Veritas Genetics Acquires Curoverse

Vividion Therapeutics Acquires Tavros Therapeutics

January 12, 2025

Biotechnology

Vividion Therapeutics, a wholly owned subsidiary of Bayer AG, has acquired precision oncology platform company Tavros Therapeutics. The acquisition expands Vividion’s functional genomics and genomic screening capabilities, combining Tavros’s platform with Vividion’s chemoproteomics expertise to accelerate discovery of novel targets in oncology and immunology; financial terms were not disclosed.

Vizgen Acquires Ultivue (Merger to Form Combined Spatial Biology Company)

October 9, 2024

Biotechnology

Vizgen and Ultivue have merged to create a single spatial biology company that combines Vizgen’s MERFISH single-cell spatial genomics platform with Ultivue’s InSituPlex assays and STARVUE proteomic/AI capabilities. Rob Carson (former CEO of Ultivue) will serve as President and CEO of the combined Vizgen, and the transaction was completed alongside Vizgen’s Series D financing backed by investors including ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.

Novartis Acquires Vedere Bio

September 30, 2020

Biotechnology

Novartis has acquired Vedere Bio, a Cambridge-based optogenetics AAV gene therapy company, for $150 million upfront plus up to $130 million in potential regulatory and clinical milestones (total consideration of $280 million). The deal includes Vedere Bio's lead preclinical intravitreal AAV programs focused on pan-genotypic vision restoration; earlier-stage assets were spun out into a newly formed independent company, Vedere Bio II.

LetsGetChecked Acquires Veritas Genetics and Veritas Intercontinental

March 29, 2022

Healthcare Services

LetsGetChecked announced it will acquire Veritas Genetics Inc. and Veritas Intercontinental to integrate whole genome sequencing and expanded genomic services into its at‑home diagnostics and virtual care platform. The deal adds capabilities across prenatal, predictive medicine, pharmacogenomics and cancer screening and positions LetsGetChecked to expand genomic offerings internationally.

TMX Group Acquires Verity from Resurgens Technology Partners

October 1, 2025

Data & Analytics

TMX Group has acquired Verity, a research management software and data analytics platform, from Resurgens Technology Partners. The deal brings Verity's research workflow and data capabilities — used by more than 300 institutional investors — into TMX Datalinx to expand TMX's investment-grade data, insights and workflow tools for asset managers and other institutional clients.

Veritas Acquires Aptare for Storage Analytics

March 6, 2019

Data & Analytics

Veritas Technologies acquired Aptare, a Campbell, California–based storage analytics vendor, to boost Veritas's storage monitoring and predictive analytics capabilities and integrate Aptare features into NetBackup and other data protection products. The acquisition (price undisclosed) brings the Aptare team into Veritas and retains the Aptare brand as a stand-alone offering while enabling deeper integration across Veritas products and cloud/on‑prem data sources.